| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allarity Therapeutics, Inc. | President and Chief Development Officer | Common Stock | 24.9K | $39.3K | $1.58 | Sep 30, 2025 | Direct |
| Allarity Therapeutics, Inc. | President and Chief Development Officer | Restricted Stock Units | 223K | Sep 30, 2025 | Direct | ||
| IN8BIO, INC. | Director | Stock Option (right to buy) | 63.2K | May 8, 2025 | Direct | ||
| IN8BIO, INC. | Director | Series B Warrants (right to buy) | 2.05K | Apr 27, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALLR | Allarity Therapeutics, Inc. | Sep 30, 2025 | 3 | -$23.1K | 4 | Oct 2, 2025 | President and Chief Development Officer |
| INAB | IN8BIO, INC. | May 8, 2025 | 1 | $0 | 4 | May 12, 2025 | Director |
| INAB | IN8BIO, INC. | Apr 27, 2025 | 2 | $0 | 4 | May 7, 2025 | Director |
| ALLR | Allarity Therapeutics, Inc. | Jan 22, 2025 | 1 | $0 | 4 | Jan 24, 2025 | CDO |
| INAB | IN8BIO, INC. | Dec 19, 2024 | 1 | $0 | 4 | Dec 23, 2024 | Director |
| ALLR | Allarity Therapeutics, Inc. | Sep 30, 2024 | 1 | $250K | 4 | Oct 1, 2024 | President and Chief Development Officer |
| ALLR | Allarity Therapeutics, Inc. | Sep 30, 2024 | 0 | $0 | 3 | Oct 1, 2024 | President and Chief Development Officer |
| INAB | IN8BIO, INC. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| INAB | IN8BIO, INC. | Dec 13, 2023 | 3 | $0 | 4 | Dec 15, 2023 | Director |
| INAB | IN8BIO, INC. | Sep 13, 2023 | 1 | $2.38K | 4 | Sep 15, 2023 | Director |
| INAB | IN8BIO, INC. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| INAB | IN8BIO, INC. | May 1, 2023 | 1 | $0 | 4 | May 3, 2023 | Director |
| INAB | IN8BIO, INC. | May 1, 2023 | 0 | $0 | 3 | May 3, 2023 | Director |